Hodgkin's disease in Indian children: Outcome with chemotherapy alone

Pediatric Blood and Cancer

Volumn 46, Issue 1, 2006, Pages 26-34

  Arya, Laxman S ^a   Dinand, Veronique ^a   Thavaraj, Vasantha ^a   Bakhshi, Sameer ^b   Dawar, Ramesh ^a   Rath, Goura K ^a   Singh, Rajvir ^a   Vats, Tribhuvan S ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

^c Tech University   (United States)

Author keywords

Chemotherapy alone; Children; Hodgkin's disease; Prognostic factors

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ANEMIA; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; DRUG EFFICACY; FEMALE; HEMATEMESIS; HODGKIN DISEASE; HUMAN; INDIAN; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; PARALYTIC ILEUS; PRIORITY JOURNAL; PROGNOSIS; RED FLUSH SYNDROME; SEIZURE; SIDE EFFECT; SKIN ALLERGY; SPLEEN; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; INDIA; MALE; MULTIVARIATE ANALYSIS; PREDNISONE; PROCARBAZINE; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; VINBLASTINE; VINCRISTINE;

EID: 28844507265     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20157     Document Type: Article

References (53)

1. Patricio MB, De Sousa JV. Hodgkin's disease in children: Seventeen years' experience at the Instituto Portugues do Oncologia de Francisco Gentil. Cancer 1981;48:1550-1556.
2. Derek R, Jenkin RD, Berry MP. Hodgkin's disease in children. Semin Oncol 1980;7:202-211.
3. Murphy SB, Davis LW. Hodgkin's disease and the non-Hodgkin's lymphomas in childhood. Semin Oncol 1974;1:17-26.
4. Weiner M, Leventhal B, Brecher ML, et al. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: A Pediatric Oncology Group study. J Clin Oncol 1997;15:2769-2779.
5. Donaldson SS, Link MP. Combined modality treatment with low dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 1987;5:742-749.
6. Jenkin D, Doyle J, Berry M, et al. Hodgkin's disease in children: Treatment with MOPP and low dose, extended field irradiation without laparotomy. Late results and toxicity. Med Pediatr Oncol 1990;18:265-272.
7. Fryer CJ, Hutchinson RJ, Krailo M, et al. Efficacy and toxicity of 12 courses of ABVD followed by low-dose regional radiation in advanced Hodgkin's disease in children: A report of the Children's Cancer Study Group. J Clin Oncol 1990;8:1971-1980.
8. Oberlin O, Lerverger G, Pacquement MA, et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: The experience of the French Society of Pediatric Oncology. J Clin Oncol 1992;10:1602-1608.
9. Schellong G, Branswig J, Horniz Franz I, et al. Treatment of children with Hodgkin's disease: Results of the German Pediatric Oncology Group. Ann Oncol 1992;4:73-76.
10. Hunger SP, Link MP, Donaldson SS. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. J Clin Oncol 1994;12:2160-2166.
11. Schellong G, Pötter R, Brämswig J, et al. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90. J Clin Oncol 1999;17:3736-3744.
12. Landman-Parker J, Pacquement H, Leblanc T, et al. Localized childhood Hodgkin's disease: Response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisolone before low-dose radiation therapy-results of the French Society of Pediatric Oncology study MDH90. J Clin Oncol 2000;18:1500-1507.
13. Probert JC, Parker BP. The effect of radiation therapy on bone growth. Radiology 1975;114:155-162.
14. Canellos GP, Anderson JR, Propert KJ, et al. chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992;327:1478-1484.
15. Carbone C, Kaplan HS, Musshoff F, et al. Report of the committee on Hodgkin's disease staging. Cancer Res 1971;31:1860-1861.
16. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966;26:1063-1081.
17. De Vita VT, Jr., Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Int Med 1970;73:881-895.
18. Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin's disease with Adriamycin, Bleomycin, Vinblastin, and Imidazole Carboxamide versus MOPP. Cancer 1975;36:252-259.
19. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
20. Correa P, O'Conor GT. Epidemiologic patterns of Hodgkin's disease. Int J Cancer 1971;8:192-201.
21. Mac Mahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966;26:1189-1200.
22. Fraumeni JF, Jr., Li FP. Hodgkin's disease in childhood: An epidemiologic study. J Natl Cancer Inst 1969;42:681-691.
23. Dinshaw K, Pande S, Advani S, et al. Pediatric Hodgkin's disease in India. J Clin Oncol 1985;3:1605-1612.
24. Kapoor G, Advani SH, Dinshaw KA, et al. Treatment results of Hodgkin's disease in Indian children. Pediatr Hematol Oncol 1995;12:559-569.
25. Sripada PV, Tenali SG, Vasudevan M, et al. Hybrid (COPP/ABV) therapy in childhood Hodgkin's disease: A study of 53 cases during 1988-1993 at the Cancer Institute, Madras. Pediatr Hemat Oncol 1995;12:333-341.
26. Arya LS, Thavaraj V, Dawar R, et al. Hodgkin's disease in Indian children: Report from a major referral centre. Med Pediatr Oncol 2000;35:203.
27. Olweny CLM, Katongole-Mbidde E, Kiire C, et al. Childhood Hodgkin's disease in Uganda. Cancer 1978;42:787-792.
28. Gad-El-Mawla N, El-Deeb BB, Abu-Gabal A, et al. Pediatric Hodgkin's disease in Egypt. Cancer 1983;52:1129-1131.
29. Çavdar AO, Pamir A, Gözdasoglu S, et al. Hodgkin's disease in children: Clinicoepidemiologic and viral (Epstein-Barr virus) analyses. Med Pediatr Oncol 1999;32:18-24.
30. Shankar AG, Ashley S, Radford M, et al. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group. J Clin Oncol 1997;15:2622-2630.
31. Nandakumar A, Anantha N, Appaji L, et al. Descriptive epidemiology of childhood cancers in Bangalore, India. Cancer Causes Control 1996;7:405-410.
32. Baez F, Ovampo E, Conter V, et al. Treatment of childhood Hodgkin's disease with COPP or COPP/ABV (hybrid) without radiotherapy in Nicaragua. Ann Oncol 1997;8:247-250.
33. Faria SL, Vassalo J, Cosset JM, et al. Childhood Hodgkin's disease in Campinas, Brazil. Med Pediatr Oncol 1996;26:90-94.
34. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 1997;70:375-382.
35. Ambinder RF, Bronwing PJ, Lorenzana I, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and in the United States. Blood 1993;81:462-467.
36. Weinreb M, Day PJR, Niggli F, et al. The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas. Arch Dis Child 1996;74:27-31.
37. Weinreb M, Day PJ, Murray P, et al. Epstein-Barr virus (EBV) and Hodgkin's disease in children: Incidence of EBV latent membrane protein in malignant cells. J Pathol 1992;168:365-369.
38. Brousset P, Rochaix P, Chittal S, et al. High incidence of detection of Epstein-Barr virus in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993;23:189-191.
39. Claviez A, Tiemann M, Peters J, et al. The impact of EBV, proliferation rate, and bcl-2 expression in Hodgkin's disease in childhood. Ann Hematol 1994;68:61-66.
40. Longo DL. Chemotherapy alone in the treatment of patients with early stage Hodgkin's disease. Ann Oncol 1996;7:S85-S89.
41. Ekert H, Waters KD, Smith PJ, et al. Treatment with MOPP or Ch1VPP chemotherapy only for all stages of childhood Hodgkin's disease. J Clin Oncol 1988;6:1845-1850.
42. Behrendt H, van Bunningen BN, van Leeuwen EF. Treatment of Hodgkin's disease in children with or without radiotherapy. Cancer 1987;59:1870-1873.
43. Yaniv I, Saab A, Cohen IJ, et al. Hodgkin's disease in children: Reduced tailored chemotherapy for stage I-II disease. J Pediatr Hematol Oncol 1996;18:76-90.
44. Van den Berg H, Stuve W, Behrendt H. Treatment of Hodgkin's disease in children with alternating Mechlorethamine, Vincristine, Procarbazine, and Prednisolone (MOPP) and Adriamycin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) courses without radiotherapy. Med Pediatr Oncol 1997;29:23-27.
45. Hutchinson RJ, Fryer CJH, Charlton Davis P, et al. MOPP or irradiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: Results of the Children's Cancer Group phase III trial. J Clin Oncol 1998;16:897-906.
46. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-751.
47. Muwakkit S, Geara F, Nabbout B, et al. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. Radiat Oncol Inverstig 1999;7:365-373.
48. Lipschultz SE, Sallan SE. cardiovascular abnormalities in long-term survivors of childhood cancer. J Clin Oncol 1993;11:1199-1203.
49. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-1215.
50. Mefferd JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease: Pulmonary, cardiac, and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 1989;16:679-685.
51. Nysom K. Risk factors for reduced pulmonary function after malignant lymphoma in childhood. Med Pediatr Oncol 1998;30:240-248.
52. Bossi G, Cerveri I, Volpini E, et al. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease. Ann Oncol 1997;8:19-24.
53. Hudson MM, Greenwald C, Thompson E, et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 1993;11:100-108.